Comment on Report: Drug-maker Actavis near deal to buy Allergan

Report: Drug-maker Actavis near deal to buy Allergan

Actavis is close to a deal to buy Allergan Inc. for more than $62.5 billion, a transaction that would help the maker of Botox rebuff a hostile advance from Valeant Pharmaceuticals International Inc., said people with knowledge of the matter. A deal...

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News